Abstracts tagged "Early Rheumatoid Arthritis and comorbidity"

Abstract Number: 1537 • 2016 ACR/ARHP Annual Meeting
Prevalence and Impact of Inflammatory Multimorbid Conditions on Trajectories of Disease Activity in the First Year of Follow-up in a Multi-Center Era Cohort
Orit Schieir¹, Susan J. Bartlett², Carol Hitchon³, Janet E. Pope⁴, Gilles Boire⁵, Boulos Haraoui⁶, Edward C. Keystone⁷, Carter Thorne⁸, Diane Tin⁹ and Vivian P. Bykerk¹⁰, ¹McGill University, Montreal, ON, Canada, ²Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, ³University of Manitoba, Winnipeg, MB, Canada, ⁴University of Western Ontario, St Joseph's Health Care, London, ON, Canada, ⁵Rheumatology Division, CHUS - Sherbrooke University, Sherbrooke, QC, Canada, ⁶Institut de Rhumatologie de Montréal, Montreal, QC, Canada, ⁷Mount Sinai Hospital, Toronto, ON, Canada, ⁸University of Toronto and Southlake Regional Health Centre, Newmarket, ON, Canada, ⁹The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, ¹⁰Divison of Rheumatology, Hospital for Special Surgery, New York, NY
Background/Purpose: Patients with rheumatoid arthritis also commonly report other chronic conditions (“multimorbidity”) with higher counts of conditions associated with reduced response to treatment and persistent…
Abstract Number: 1556 • 2016 ACR/ARHP Annual Meeting
Assessment of the Burden of Comorbidities By the Rheumatic Disease Comorbidity Index in Early Rheumatoid Arthritis Patients at Disease Onset
Veerle Stouten¹, Diederik De Cock¹, Rene Westhovens^1,2, Johan Joly², Kristien Van der Elst^2,3 and Patrick Verschueren^1,2, ¹KU Leuven Department of Development and Regeneration, Skeletal Biology and Engineering Research Center, Leuven, Belgium, ²Rheumatology, University Hospitals Leuven, Leuven, Belgium, ³KU Leuven, Department of Public Health and Primary Care, Skeletal Biology and Engineering Research Center, Leuven, Belgium
Background/Purpose: Rheumatoid Arthritis (RA) is associated with a high prevalence of comorbidities, negatively affecting outcomes like disease activity and physical function. However, not all comorbid…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].